Fluticasone Propionate
- Product NDC
- 51672-4095
- 11-digit product format
- 516724095
- Labeler code
- 51672
- Product ID
- 51672-4095_ec64eb18-f4ff-438e-bb6e-a089f963847b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fluticasone Propionate
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Taro Pharmaceuticals U.S.A., Inc.
- Application
- ANDA077145
- Marketing category
- ANDA
- Marketing start
- 2005-06-14
- Marketing end
- 0000-00-00
- Substance
- FLUTICASONE PROPIONATE
- Active strength
- 0 mg/g
- Pharmacologic classes
- Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 51672-4095-1 | 2020-02-04 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
| 51672-4095-2 | 2020-02-04 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
| 51672-4095-3 | 2020-02-04 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
| 51672-4095-5 | 2020-02-04 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
| 51672-4095-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
| 51672-4095-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
| 51672-4095-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
| 51672-4095-5 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-242a-f424-e053-dadaa90a57ce | ff96762d-a841-4558-befd-d14761bbe6fc |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Fluticasone Propionate | ACTIVE INGREDIENT | O2GMZ0LF5W | FLUTICASONE PROPIONATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Fluticasone | ACTIVE MOIETY | CUT2W21N7U | FLUTICASONE PROPIONATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| microcrystalline wax | INACTIVE INGREDIENT | XOF597Q3KY | FLUTICASONE PROPIONATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | FLUTICASONE PROPIONATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | FLUTICASONE PROPIONATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| sorbitan sesquioleate | INACTIVE INGREDIENT | 0W8RRI5W5A | FLUTICASONE PROPIONATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4095 | FLUTICASONE PROPIONATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Legacy NDC | 20241222_ff96762d-a841-4558-befd-d14761bbe6fc.zip |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 51672-4095-1 | 51672409501 | 1 TUBE in 1 CARTON (51672-4095-1) > 15 g in 1 TUBE | 1 tube | 2005-06-14 | 0000-00-00 | No | No | Current |
| 51672-4095-2 | 51672409502 | 1 TUBE in 1 CARTON (51672-4095-2) > 30 g in 1 TUBE | 1 tube | 2005-06-14 | 0000-00-00 | No | No | Current |
| 51672-4095-3 | 51672409503 | 1 TUBE in 1 CARTON (51672-4095-3) > 60 g in 1 TUBE | 1 tube | 2005-06-14 | 0000-00-00 | No | No | Current |
| 51672-4095-5 | 51672409505 | 5 g in 1 TUBE (51672-4095-5) | 5 g | 2005-06-14 | 0000-00-00 | No | No | Current |